SPHERA FUNDS MANAGEMENT LTD. - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 62 filers reported holding IMMUNE DESIGN CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2016$567,000
-63.2%
103,000
-49.3%
0.14%
-42.6%
Q3 2016$1,539,000
+23.3%
203,000
+32.7%
0.25%
-22.5%
Q2 2016$1,248,000
-37.3%
153,0000.0%0.32%
-24.8%
Q1 2016$1,989,000
-35.3%
153,0000.0%0.43%
-4.2%
Q4 2015$3,072,000
+48.1%
153,000
-10.0%
0.45%
+69.8%
Q3 2015$2,074,000
-28.3%
170,000
+21.4%
0.26%
-6.4%
Q2 2015$2,891,000
+5.8%
140,000
+8.2%
0.28%
-0.4%
Q1 2015$2,732,000129,4400.28%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders